Viking Therapeutics
VKTX
VKTX
193 hedge funds and large institutions have $1.21B invested in Viking Therapeutics in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 184 → 193 (+9)
9.84% less ownership
Funds ownership: 84.75% → 74.91% (-9.8%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
193
Holding in Top 10
2
Calls
$95.3M
Puts
$47.3M
Top Buyers
| 1 | +$78.7M | |
| 2 | +$65.7M | |
| 3 | +$47.8M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$25.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$22M |
Top Sellers
| 1 | -$32.7M | |
| 2 | -$25.1M | |
| 3 | -$20.2M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$17.5M |
| 5 |
Two Sigma Advisers
New York
|
-$14.9M |